THERABEL PHARMACEUTICALS LIMITED

Therabel Pharmaceuticals Limited is a collaborative, agile player in the pharmaceutical sector, built around the belief that "partnership is in our genes". The company's business model centres on forming strategic alliances with other pharmaceutical firms, physicians and pharmacists to bring both prescription-only franchises and over-the-counter (OTC) categories to market. By sharing expertise and resources, Therabel aims to achieve operational excellence and accelerate product development across a global footprint.

With a 2019 group turnover of €59.1 million, Therabel's portfolio spans a range of prescription medicines and consumer health products, supported by a clear business-development strategy and a suite of partner benefits. Its collaborative culture and responsible approach underpin a focus on delivering value to healthcare professionals and patients alike, positioning the company as a trusted partner in the international pharma landscape.